A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient

Pretransplant Immunologic Risk Assessment of Kidney Transplant Recipients With Donor-Specific Anti–Human Leukocyte Antigen Antibodies

(2014) Kwaku Marfo et al.   TRANSPLANTATION

Proteasome inhibitor-based therapy for antibody-mediated rejection

(2012) R. Carlin Walsh et al.   KIDNEY INTERNATIONAL

Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation

(2012) Jennifer M. DeVos et al.   KIDNEY INTERNATIONAL

De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy

(2012) Michelle Willicombe et al.   TRANSPLANTATION

The Treatment of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients—A Systematic Review

(2012) Darren M. Roberts et al.   TRANSPLANTATION

Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection

(2011) J. Waiser et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Antibody-Mediated Rejection After Alemtuzumab Induction: Incidence, Risk Factors, and Predictors of Poor Outcome

(2011) Michelle Willicombe et al.   TRANSPLANTATION